166 related articles for article (PubMed ID: 36480278)
1. Worldwide Consensus on Thyroid Eye Disease? What Is In a Name?
Wiersinga WM
Thyroid; 2022 Dec; 32(12):1431-1433. PubMed ID: 36480278
[No Abstract] [Full Text] [Related]
2. [The stepwise establishment of standardized treatment for the thyroid eye disease].
Qian J
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):404-407. PubMed ID: 28606260
[TBL] [Abstract][Full Text] [Related]
3. Thyroid eye disease: a review.
Weiler DL
Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
[TBL] [Abstract][Full Text] [Related]
4. A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
Douglas RS; Goldberg RA; Smith TJ
Thyroid; 2008 Sep; 18(9):931. PubMed ID: 18788916
[No Abstract] [Full Text] [Related]
5. Thyroid Eye Disease: A New Name, A New Guide, and A New Era.
Davies TF
Thyroid; 2022 Dec; 32(12):1434-1436. PubMed ID: 36480286
[No Abstract] [Full Text] [Related]
6. [Therapy-resistant thyroid diseases. 1.Graves' ophthalmopathy].
Hiromatsu Y
Nihon Naika Gakkai Zasshi; 2010 Apr; 99(4):755-62. PubMed ID: 20578362
[No Abstract] [Full Text] [Related]
7. Evaluation and management of Graves' orbitopathy.
Lee HB; Rodgers IR; Woog JJ
Otolaryngol Clin North Am; 2006 Oct; 39(5):923-42, vi. PubMed ID: 16982255
[TBL] [Abstract][Full Text] [Related]
8. Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Burch HB; Perros P; Bednarczuk T; Cooper DS; Dolman PJ; Leung AM; Mombaerts I; Salvi M; Stan MN
Thyroid; 2022 Dec; 32(12):1439-1470. PubMed ID: 36480280
[TBL] [Abstract][Full Text] [Related]
9. Practical Guidelines Management of Graves Ophthalmopathy.
Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
[TBL] [Abstract][Full Text] [Related]
10. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy.
Parmar H; Ibrahim M
Neuroimaging Clin N Am; 2008 Aug; 18(3):527-36, viii-ix. PubMed ID: 18656033
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
12. [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
Bednarczuk T; Bar-Andziak E; Hubalewska-Dydejczyk A; Waligórska A; Górska M; Myśliwiec J; Jarzab B; Karczmarzyk R; Zawadzka A; Garmol D; Kecik D; Królicki L; Plazińska MT; Krzeski A; Krzyzanowska-Swiniarska B; Lewiński A; Milewicz A; Daroszewski J; Placzkiewicz-Jankowska E; Pilarska K; Skórski M; Wiechno W; Sowiński J; Syrenicz A; Szafilk J; Wanyura H; Zgliczński W; Jastrzebska H; Nauman J
Endokrynol Pol; 2009; 60(4):312-30. PubMed ID: 19753546
[No Abstract] [Full Text] [Related]
13. Evaluating the Thyroid Eye Disease Patient.
Denisova K; Barmettler A
Int Ophthalmol Clin; 2021 Apr; 61(2):33-52. PubMed ID: 33743527
[No Abstract] [Full Text] [Related]
14. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
15. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
[No Abstract] [Full Text] [Related]
16. Pediatric hyperthyroidism and thyroid eye disease management.
Li J; Austin J; Douglas RS; Nallasamy S
J AAPOS; 2023 Jun; 27(3):123-128. PubMed ID: 37182650
[No Abstract] [Full Text] [Related]
17. Pediatric hyperthyroidism and thyroid eye disease management.
Adeoye O; Nwokeji I; Madu CT
J AAPOS; 2023 Dec; 27(6):382. PubMed ID: 37939915
[No Abstract] [Full Text] [Related]
18. [Choice the appropriate therapy according to the clinical features of the thyroid associated ophthalmopathy].
Xiao LH
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1060-2. PubMed ID: 17415960
[TBL] [Abstract][Full Text] [Related]
19. Thyroid eye disease.
Perros P; Neoh C; Dickinson J
BMJ; 2009 Mar; 338():b560. PubMed ID: 19270020
[No Abstract] [Full Text] [Related]
20. Management plan and delivery of care in Graves' ophthalmopathy patients.
Yang M; Perros P
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):303-11. PubMed ID: 22632367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
